MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 139 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q4 2015. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $27,000 | -67.9% | 5,000 | -50.0% | 0.00% | -100.0% |
| Q1 2016 | $84,000 | -57.6% | 10,000 | -60.0% | 0.00% | -75.0% |
| Q4 2015 | $198,000 | -7.0% | 25,000 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $213,000 | -24.2% | 25,000 | +10.1% | 0.00% | -20.0% |
| Q2 2015 | $281,000 | +4.1% | 22,700 | 0.0% | 0.01% | 0.0% |
| Q1 2015 | $270,000 | +42.9% | 22,700 | +35.9% | 0.01% | +25.0% |
| Q4 2014 | $189,000 | +42.1% | 16,700 | +9.9% | 0.00% | 0.0% |
| Q3 2014 | $133,000 | +19.8% | 15,200 | 0.0% | 0.00% | +33.3% |
| Q2 2014 | $111,000 | +44.2% | 15,200 | 0.0% | 0.00% | +50.0% |
| Q1 2014 | $77,000 | -4.9% | 15,200 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $81,000 | +376.5% | 15,200 | +508.0% | 0.00% | +100.0% |
| Q2 2013 | $17,000 | – | 2,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 514,853 | $2,595,000 | 2.23% |
| GARRISON BRADFORD & ASSOCIATES INC | 98,001 | $494,000 | 0.48% |
| Catalyst Capital Advisors LLC | 380,896 | $1,920,000 | 0.44% |
| Knoll Capital Management, LLC | 160,585 | $809,000 | 0.42% |
| Tekla Capital Management LLC | 757,050 | $3,816,000 | 0.38% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 524,800 | $2,645,000 | 0.13% |
| Integre Asset Management, LLC | 103,493 | $522,000 | 0.12% |
| CAMBRIDGE TRUST CO | 220,003 | $1,109,000 | 0.10% |
| JAMISON EATON & WOOD INC /NJ | 62,782 | $316,000 | 0.09% |
| STONERIDGE INVESTMENT PARTNERS LLC | 88,304 | $445,000 | 0.09% |